Akışa dönSiteyi ziyaret et
Aday dosyasıİniş18:41
Hplus therapeutics — Geneva based biotech
hplus-therapeutics.ch · Keşfedildi 1 sa. önce
Özet
HPlus Therapeutics develops first-in-class Hv1 proton channel inhibitors for solid tumors. 8 lead candidates from 60K+ compounds screened. Geneva-based biotech.
- Kitle
- General
- Kategori
- Other
- Ülke
- Switzerland
- Durum
- Live